ENDOCYTE INC (ECYT) has 49 open-market insider trades by 20 insiders since 2011. The most active filer is Christopher P. Leamon, President & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| V. Ltd Partnership Sanderling | 10% | — | 2 | $6.0M | 2011-12-21 |
| Fred A. Middleton | Dir | — | 5 | $5.3M | 2018-12-21 |
| Ann Hanham | Dir | — | 7 | $5.2M | 2017-05-04 |
| V. Beteiligungs Gmbh & Co Kg Sanderling | 10% | — | 1 | $1.4M | 2011-12-21 |
| Christopher P. Leamon | PresVP | — | 8 | $1.2M | 2018-12-21 |
| Philip S. Low | CSO | — | 7 | $957K | 2018-12-21 |
| Ventures Management V. Sanderling | 10% | — | 4 | $453K | 2012-12-11 |
| Michael A. Sherman | CEOPres | — | 1 | $438K | 2018-12-21 |
| Binh Nguyen | VP of Medical Affairs | — | 2 | $422K | 2015-03-03 |
| Douglas G. Bailey | Dir | — | 1 | $420K | 2011-12-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael A. Sherman | CEO & President | Sell | $875K | 2018-10-05 |
| Christopher P. Leamon | President & VP | Sell | $281K | 2018-10-05 |
| Alison A. Armour | — | Sell | $284K | 2018-10-05 |
| Michael T. Andriole | CFO | Sell | $548K | 2018-10-05 |
| Erik C. Chelius | President & VP | Sell | $140K | 2018-10-05 |
| Beth Taylor | VP | Sell | $219K |
Companies that share insiders with ECYT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-10-05 |
| Philip S. Low | CSO | Sell | $184K | 2018-10-05 |
| Katherine Parker | VP | Sell | $211K | 2018-10-05 |
| Christopher P. Leamon | President & VP | Sell | $347K | 2018-08-28 |
| Beth Taylor | VP | Sell | $158K | 2018-08-28 |
| Beth Taylor | VP Finance & Chief Acctg Offcr | Sell | $5K | 2018-08-20 |
| Alison A. Armour | Chief Medical Officer | Sell | $23K | 2018-08-01 |
| Christopher P. Leamon | President & VP | Sell | $394K | 2018-06-12 |
| Christopher P. Leamon | President & VP | Sell | $46K | 2018-03-09 |
| Philip S. Low | CSO | Sell | $446K | 2017-12-28 |